Healthcare Taiwanese Clinical Laboratory Instrumentation Markets

 

INDUSTRY
Healthcare

RELEASE DATE
12-Oct-2006
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
4A0F-01-00-00-00
SKU
HC00119-AP-MR_02935
Yes
SHARE

Taiwanese Clinical Laboratory Instrumentation Markets
Published on: 12-Oct-2006 | SKU: HC00119-AP-MR_02935

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The clinical laboratory instrumentation (CLI) market in Taiwan is a mature market that is approaching saturation. Taiwan has one of the best healthcare systems in Asia Pacific after Japan and offers both modern and comprehensive medical services to its population. The CLI market in Taiwan was valued at approximately $67.0 million in 2005 and is expected to grow by about 4.0 percent in 2006. The market is expected to experience of compound annual growth rate (CAGR) of 5.9 percent driven by strong growth in molecular diagnostics product segment. Growth in core market segments of clinical chemistry, immunochemistry and hematology remain modest with growth expected to pick up towards the end of the forecast period.


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The clinical laboratory instrumentation (CLI) market in Taiwan is a mature market that is approaching saturation. Taiwan has one of the best healthcare systems in Asia Pacific after Japan and offers both modern and comprehensive medical services to its population. The CLI market in Taiwan was valued at approximately $67.0 million in 2005 and is expected to grow by about 4.0 percent in 2006. The market is expected to experience of compound annual growth rate (CAGR) of 5.9 percent driven by strong growth in molecular diagnostics product segment. Growth in core market segments of clinical chemistry, immunochemistry and hematology remain modest with growth expected to pick up towards the end of the forecast period.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number 4A0F-01-00-00-00
Is Prebook No

Taiwanese Clinical Laboratory Instrumentation Markets

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC00119-AP-MR_02935